Cardiology
AHA Scientific Statement: Evolving Diagnosis and Management of Cardiac Amyloidosis
2 Jun, 2020 | 04:53h | UTCRelated: Cardiac Amyloidosis: Updates in Imaging (several reviews on the subject) AND AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management – JACC: CardioOncology AND Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis – Canadian Journal of Cardiology
Association of Dairy Consumption with Metabolic Syndrome, Hypertension and Diabetes in 147 812 Individuals from 21 Countries
2 Jun, 2020 | 04:52h | UTCCommentary: Study shows dairy products are linked to lower risks of diabetes and high blood pressure – News Medical
Comprehensive Geriatric Assessment in the Management of Older Patients With Cardiovascular Disease
2 Jun, 2020 | 04:51h | UTC
Study: Ramipril in High Risk Patients with COVID-19
1 Jun, 2020 | 03:53h | UTCRamipril in High Risk Patients with COVID-19 – Journal of the American College of Cardiology
[Abstract Only] Study: Primary Aldosteronism Common and Largely Unrecognized in Patients with Hypertension
1 Jun, 2020 | 03:41h | UTCThe Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study – Annals of Internal Medicine (link to abstract – $ for full-text)
Study: No Evidence Blanket ‘Do-not-resuscitate’ Orders for COVID-19 Patients are Necessary
28 May, 2020 | 09:50h | UTC
Study: Early Cardiac MRI in Patients with Troponin-positive Acute Chest Pain and Non-obstructed Coronary Arteries
28 May, 2020 | 09:33h | UTC
Clinical Guidance: Advanced Pulmonary and Cardiac Support of COVID-19 Patients
27 May, 2020 | 02:27h | UTC
Randomized Trial: Antihypertensive Medication Reduction vs. Usual Care Among Older Adults Taking Multiple Antihypertensive Medications
27 May, 2020 | 02:16h | UTC
Related Commentary on Twitter
Less is more? Our new trial suggests #deprescribing #bloodpressure lowering medications is safe in the short-term in older people with frailty and multimorbidity – see thread for details https://t.co/fLf2Vv42hB #hypertension #RCT @richardjmcmanus @jenniaburt @HomeUrs29 @prof_mant pic.twitter.com/HfScHju6HS
— James Sheppard (@jamessheppard48) May 26, 2020
[Abstract Only] Study: Estimating the Lifetime Benefits of a Multi-drug Regimen for Heart Failure
27 May, 2020 | 02:41h | UTCEstimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials – The Lancet (link to abstract – $ for full-text)
Related Commentary on Twitter
NEW Research—Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trialshttps://t.co/XjRPvdU7tK pic.twitter.com/ZAjynxPdAK
— The Lancet (@TheLancet) May 22, 2020
Review: COVID-19 and Cardiovascular Disease
26 May, 2020 | 10:05h | UTCCOVID-19 and Cardiovascular Disease – Circulation
Related Guidelines: COVID-19 rapid guideline: acute myocardial injury – National Institute for Health and Care Excellence AND ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology AND Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology
Wide Complex Tachycardia Differentiation: A Reappraisal of the State‐of‐the‐Art
22 May, 2020 | 04:38h | UTC
Meta-Analysis: Complete vs. Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction
22 May, 2020 | 04:36h | UTCComplete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis – JAMA Cardiology (free for a limited period)
Characteristics and Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease
21 May, 2020 | 09:18h | UTCCommentary: Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease – American College of Cardiology
Cardiovascular Considerations in Treating Patients with COVID-19
21 May, 2020 | 09:16h | UTCRelated: Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis – Current Problems in Cardiology AND Cardiology After COVID-19: Physicians Predict Lasting Change – TCTMD
See also: COVID-19: Updates for Cardiologists
Study Shows Lower Incidence of Hospitalization for Acute Myocardial Infarction After the Covid-19 Pandemic
20 May, 2020 | 09:54h | UTCRelated Study: Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy – New England Journal of Medicine
Meta-Analysis: ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19
20 May, 2020 | 09:50h | UTCRelated Study (Preprint): Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 – medRxiv
Meta-Analysis: Association of Blood Pressure Lowering with Incident Dementia or Cognitive Impairment
20 May, 2020 | 09:45h | UTCAssociation of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis – JAMA (free for a limited period)
Commentary: Controlling blood pressure may reduce dementia risk by 7% – UPI
Covid-19 Case Series: Acute Heart Failure in Multisystem Inflammatory Syndrome in Children
19 May, 2020 | 04:37h | UTCRelated Case Report: Cardiac dysfunction and thrombocytopenia-associated multiple organ failure inflammation phenotype in a severe paediatric case of COVID-19 – The Lancet Child & Adolescent Health
Related Commentary on Twitter
3 reports of #COVID in children and adolescents today:
35 kids w/ multi-organ inflammatory syndrome and heart failure https://t.co/0gMMS7Kgdm
3 kids w/ skin presentations @TheLancetInfDis https://t.co/WwafDSMA8p
Adolescent like top above @LancetChildAdol https://t.co/AbSkLbN6On pic.twitter.com/vsfpNT173A— Eric Topol (@EricTopol) May 18, 2020
Systematic Review: Risks and Impact of ACE Inhibitors or ARBs on SARS-CoV-2 Infection in Adults
18 May, 2020 | 01:47h | UTC
Study: Use of Renin–angiotensin–aldosterone System Inhibitors Does Not Increase the Risk of COVID-19 Requiring Admission to Hospital
18 May, 2020 | 01:45h | UTCCommentary: Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19 – The Lancet
Description of an Outbreak of Severe Kawasaki-like Disease at the Italian Epicenter of the SARS-CoV-2 Epidemic
15 May, 2020 | 03:53h | UTCCommentaries: Kawasaki-like disease: emerging complication during the COVID-19 pandemic – The Lancet AND Kawasaki-like COVID-19 complication found in Italian kids – CIDRAP AND What we know about the new Covid-19-linked illness in children – Vox AND Coronavirus: Children affected by rare Kawasaki-like disease – BBC
Related: Case Series: Hyperinflammatory Shock in Children During COVID-19 Pandemic
Cohort Study: Sugar‐Sweetened Beverage Intake Linked to Increased Cardiovascular Disease Risk
15 May, 2020 | 03:24h | UTCCommentary: Drinking sugary drinks daily may be linked to higher risk of CVD in women – American Heart Association AND Gulping down 1 or more sugary drinks a day could put you at risk for cardiovascular disease – CNN
Meta-Analysis: Prognosis of Unrecognized Myocardial Infarction Determined by ECG or Cardiac MRI
12 May, 2020 | 03:10h | UTC
Comparison Approaches to Lipid Management: AHA/ACC vs. ESC/EAS Guidelines
12 May, 2020 | 03:07h | UTC